Breast cancer recurrence combined with liver metastasis is already in advanced stage, and the prognosis is usually poor, with some studies claiming that the 5-year survival rate is less than 25%, which varies from person to person. Breast cancer is one of the most prevalent malignant tumors in women worldwide. Among newly diagnosed breast cancer patients, 6% to 7% are accompanied by metastasis to distant organs, and distant metastasis is an important cause of death for breast cancer patients. Breast cancer recurrence combined with liver metastasis to the liver indicates that the disease is already in an advanced stage. According to some studies, the overall survival rate of patients with breast cancer combined with liver metastasis in 3 and 5 years is 34.9% and 21.4% respectively, and the disease-specific survival rate of patients in 3 and 5 years is 37.0% and 23.5% respectively. And the prognosis of patients with recurrent breast cancer combined with liver metastasis is often worse. Patients with recurrent breast cancer combined with liver metastasis can choose drug therapy, chemotherapy, radiotherapy, interventional therapy, etc. according to the situation, and actively cooperate with the treatment to control the disease progression and prolong the survival time. In conclusion, when breast cancer recurrence is combined with liver metastasis, the treatment plan should be based on the comprehensive judgment of the situation, and it is often a multidisciplinary comprehensive treatment. It is recommended to go to regular hospitals to evaluate the condition and follow the doctor’s instructions to avoid delaying the condition.